Desferrioxamine Mesilate (desferrioxamine): Reviews and patient testimonials
Back to the list of medications
Medication indications
Desferrioxamine Mesilate 500 mg and 2 g Powder for Injection
Iron overload - acute iron poisoning; primary and secondary haemochromatosis including thalassaemia and transfusional haemosiderosis; in patients in whom concomitant disorders (e.g. severe anaemia, hypoproteinaemia, renal or cardiac failure) preclude phlebotomy; and for the diagnosis of iron storage disease and sideroblastic anaemia, auto-immune haemolytic anaemia and other chronic anaemias.
Aluminium overload - in patients on maintenance dialysis for end stage renal failure where preventative measures (e.g. reverse osmosis) have failed and with proven aluminium-related bone disease and/or anaemia, dialysis encephalopathy; and for diagnosis of aluminium overload.
Route of administration: Injectable
Molecule: desferrioxamine
Patients' opinions on Desferrioxamine Mesilate
Conditions related to this medication
Fact sheet
See the fact sheet
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.